Concepedia

Céline Tiffon

CT

7

Publications

461

Citations

7

H-Index

2003

Active since

Affiliations

Centre Antoine Lacassagne(Current)

Institut National du Cancer

Université Grenoble Alpes

Hôpital Intercommunal de Créteil

Centre Georges François Leclerc

Céline Tiffon is an author at Centre Antoine Lacassagne specializing in pharmacotherapy, molecular oncology, and clinical trials.

Top concepts

Publications per year

2003–2020

7

Publications

7

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

Julien Mazières, Claire Cropet, Laure Montané et al. · Annals of Oncology · 2020 · 185 citations

Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil

Nicolas Magné, J-L Fischel, Céline Tiffon et al. · British Journal of Cancer · 2003 · 77 citations · Full text

Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma

Sonja Sibold, Vincent Roh, Adrian Keogh et al. · FEBS Letters · 2007 · 57 citations

ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.

Nicolas Magné, Jean–Louis Fischel, A Dubreuil et al. · PubMed · 2003 · 54 citations

Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer

Eliane Angst, Sonja Sibold, Céline Tiffon et al. · British Journal of Cancer · 2006 · 53 citations · Full text

Rows per page

1–5 of 7